-
Pyrazoline B Induces Oxidative Stress Mediated Toxicity, Cell Cycle Arrest, and Caspase-Independent Apoptosis in BT-474 Human Breast Cancer Cells
13 Dec 2025 10:08 GMT
… -2 activity, such as lapatinib, sunitinib, erlotinib, and sorafenib.65,73 … vascular endothelial growth factor in lung cancer. Oncol Lett. 2016;12(6 … apoptosis of non-small-cell lung cancer cells by targeting EGFR…
-
Infusion-Related Reactions Among Cancer Patients Receiving Immune Checkpoint Inhibitors: The ARON-MOUSEION-013 Systematic Review and Meta-Analysis
12 Dec 2025 16:33 GMT
… kinase inhibitor (TKI) compared to sunitinib did not increase the risk … advanced squamous non-small-cell lung cancer. J Clin Oncol. 2017;35 … in metastatic non–small-cell lung cancer. N Engl J Med. 2018 … treatment of non–small-cell lung cancer. N Engl J Med. …
-
A Comprehensive Review of Advances in Molecular Mechanisms and Targeted Therapies for the Specific Type of Cystic Lung Cancer
11 Feb 2025 15:06 GMT
… is the most neuroendocrine lung tumor, and it also … Lung cancers associated with cystic airspaces: CT features and pathologic correlation. Lung Cancer … -L1 expression in rare lung tumors. Pathol Oncol Res. … phase II study of sunitinib in recurrent and…
-
Tyrosine Kinase Inhibitors Market is Forecasted to Reach a Value of US $87.14 Billion by 2029
09 Dec 2025 10:30 GMT
… Application: Chronic Myeloid Leukemia (CML), Lung Cancer, Breast Cancer, Renal Cell Cancer … (VEGFR) Tyrosine Kinase Inhibitors: Sorafenib, Sunitinib, Pazopanib, Axitinib, Regorafenib
4) By …
-
Anlotinib or Bevacizumab Combined with Taxane/Capecitabine for the Second-Line or Subsequent Treatment of HER-2 Negative Metastatic Breast Cancer: A Retrospective Cohort Study
08 Dec 2025 08:27 GMT
… , and non-small cell lung cancer. It improves objective response rate … and non-small cell lung cancers,14 and has NMPA approval … advanced breast cancer with sunitinib in combination with docetaxel … for extensive-stage small cell lung cancer (SCLC): the final …
-
CNN-based learning of single-cell transcriptomes reveals a blood-detectable multi-cancer signature of brain metastasis
22 Nov 2025 02:54 GMT
… example, on BrM in lung cancer or in breast cancer … BrMs arise most frequently from lung cancers, breast cancers, and … such as sunitinib, have demonstrated efficacy in lung cancer with brain … 1, including paired primary lung cancer and brain metastasis (BrM …
-
Lenvatinib Plus Pembrolizumab Delays Tumor Progression in All Organs vs Sunitinib in Advanced RCC
05 Jun 2024 18:17 GMT
… in all organs vs sunitinib (Sutent) in patients with advanced … organ groups. In the lung tumor group, the median time … lenvatinib and pembrolizumab compared with sunitinib,” Viktor Grünwald, MD, … of patients who received sunitinib,” Grünwald said in conclusion …
-
The Efficacy and Safety of Anlotinib in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World Study
02 Aug 2022 00:04 GMT
… to 15% of all lung cancers.1 SCLC comprises … chemotherapy for small cell lung cancer. Lung Cancer. 2006;52(3 … sunitinib in patients with relapsed or refractory small cell lung cancer. Lung Cancer … with relapsed small cell lung cancer. Lung Cancer. 2016;96:108– …
-
Ipsen: ASCO 2022: New Cabometyx® Data Show Encouraging Results in Monotherapy and in Combination Across Different Tumor Types Including Metastatic Non-Small Cell Lung Cancer
26 May 2022 21:17 GMT
… demonstrated deeper responses vs sunitinib. Regardless of treatment, … non-small cell lung cancer (NSCLC)
Lung cancer is one of … of lung cancer - NSCLC and SCLC (small cell lung cancer). … Organization: GLOBOCAN 2020 – Lung Cancer: Estimated cancer incidence, …
-
<![CDATA[The OncFive: Top Oncology Articles for the Week of 11/9]]>
15 Nov 2025 14:42 GMT
… bezuclastinib (CGT9486) to sunitinib (Sutent) significantly improved PFS vs sunitinib monotherapy in patients … , or metastatic non–small cell lung cancer (NSCLC) harboring EGFR exon 19 …
About
© 1995-2025